Hille, M.M.; Spangler, M.L.; Clawson, M.L.; Heath, K.D.; Vu, H.L.X.; Rogers, R.E.S.; Loy, J.D.
A Five Year Randomized Controlled Trial to Assess the Efficacy and Antibody Responses to a Commercial and Autogenous Vaccine for the Prevention of Infectious Bovine Keratoconjunctivitis. Vaccines 2022, 10, 916.
https://doi.org/10.3390/vaccines10060916
AMA Style
Hille MM, Spangler ML, Clawson ML, Heath KD, Vu HLX, Rogers RES, Loy JD.
A Five Year Randomized Controlled Trial to Assess the Efficacy and Antibody Responses to a Commercial and Autogenous Vaccine for the Prevention of Infectious Bovine Keratoconjunctivitis. Vaccines. 2022; 10(6):916.
https://doi.org/10.3390/vaccines10060916
Chicago/Turabian Style
Hille, Matthew M., Matthew L. Spangler, Michael L. Clawson, Kelly D. Heath, Hiep L. X. Vu, Rachel E. S. Rogers, and John Dustin Loy.
2022. "A Five Year Randomized Controlled Trial to Assess the Efficacy and Antibody Responses to a Commercial and Autogenous Vaccine for the Prevention of Infectious Bovine Keratoconjunctivitis" Vaccines 10, no. 6: 916.
https://doi.org/10.3390/vaccines10060916
APA Style
Hille, M. M., Spangler, M. L., Clawson, M. L., Heath, K. D., Vu, H. L. X., Rogers, R. E. S., & Loy, J. D.
(2022). A Five Year Randomized Controlled Trial to Assess the Efficacy and Antibody Responses to a Commercial and Autogenous Vaccine for the Prevention of Infectious Bovine Keratoconjunctivitis. Vaccines, 10(6), 916.
https://doi.org/10.3390/vaccines10060916
